Association of APOE4 genotype and treatment with cognitive outcomes in breast cancer survivors over time

Abstract This prospective longitudinal study of breast cancer survivors (n = 167) examined the association of apolipoprotein ε4 (APOE ε4) genotype with cognition and interactions with chemotherapy or endocrine therapy up to 6 years after treatment. In general, we found no effects of ε4 across timepo...

Full description

Bibliographic Details
Main Authors: Kathleen Van Dyk, Catherine M. Crespi, Julienne E. Bower, Judith E. Carroll, Laura Petersen, Patricia A. Ganz
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-021-00327-4